Gilead Sciences
GILD
1,567 hedge funds and large institutions have $63.4B invested in Gilead Sciences in 2021 Q1 according to their latest regulatory filings, with 146 funds opening new positions, 629 increasing their positions, 606 reducing their positions, and 125 closing their positions.
17% more first-time investments, than exits
New positions opened: 146 | Existing positions closed: 125
12% more capital invested
Capital invested by funds: $56.7B → $63.4B (+$6.79B)
10% more funds holding in top 10
Funds holding in top 10: 21 → 23 (+2)
8% more call options, than puts
Call options by funds: $1.72B | Put options by funds: $1.59B
4% more repeat investments, than reductions
Existing positions increased: 629 | Existing positions reduced: 606
0.58% more ownership
Funds ownership: 77.63% → 78.21% (+0.58%)
0% more funds holding
Funds holding: 1,563 → 1,567 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$873M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
+$253M |
| 3 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$174M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$172M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$162M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$420M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$355M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$223M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$194M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$180M |
GILD Hedge Fund Activity: Q1 2021 in Review
1,567 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2021, worth a combined $63.4B — up 12% from $56.7B a quarter earlier.
Buyers outnumbered sellers: 146 funds opened new GILD positions and 125 closed out — a net gain of 21 holders — while 629 added to existing stakes and 606 trimmed.
The largest buyer was BlackRock, adding an estimated $873M. The largest seller was Capital International Investors, cutting an estimated $420M.
- 1,567 institutional investors held Gilead Sciences (GILD) as of Q1 2021, up from 1,563 in Q4 2020.
- Funds reported $63.4B of Gilead Sciences stock for Q1 2021, up 12% quarter-over-quarter.
- 146 funds opened new Gilead Sciences positions in Q1 2021 and 125 closed out, a net change of +21 holders.
- The largest Gilead Sciences buyer in Q1 2021 was BlackRock, an estimated $873M added.
- The largest Gilead Sciences seller in Q1 2021 was Capital International Investors, an estimated $420M sold.
Based on aggregated 13F filings for Q1 2021.